SolventumSOLVEarnings & Financial Report
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
SOLV Q1 FY2026 Key Financial Metrics
Revenue
$2.0B
Gross Profit
$1.1B
Operating Profit
$81.0M
Net Profit
$13.0M
Gross Margin
54.7%
Operating Margin
4.0%
Net Margin
0.6%
YoY Growth
-3.0%
EPS
$0.07
Solventum Q1 FY2026 Financial Summary
Solventum reported revenue of $2.0B (down 3.0% YoY) for Q1 FY2026, with a net profit of $13.0M (0.6% margin). Cost of goods sold was $910.0M, operating expenses totaled $1.0B.
Key Financial Metrics
| Total Revenue | $2.0B |
|---|---|
| Net Profit | $13.0M |
| Gross Margin | 54.7% |
| Operating Margin | 4.0% |
| Report Period | Q1 FY2026 |
Revenue Breakdown
Solventum Q1 FY2026 revenue of $2.0B breaks down across 5 segments, led by Infection Prevention and Surgical Solutions at $737.0M (36.7% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Infection Prevention and Surgical Solutions | $737.0M | 36.7% |
| Advanced Wound Care | $497.0M | 24.8% |
| Dental Solutions | $354.0M | 17.6% |
| Health Information Systems | $342.0M | 17.0% |
| All Other 4 | $76.0M | 3.8% |
Solventum Revenue by Segment — Quarterly Trend
Solventum revenue by segment across the last 4 reported quarters, showing how each business line (such as Infection Prevention and Surgical Solutions and Advanced Wound Care) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Infection Prevention and Surgical Solutions | $737.0M | — | — | — |
| Advanced Wound Care | $497.0M | — | — | $467.0M |
| Dental Solutions | $354.0M | — | — | — |
| Health Information Systems | $342.0M | — | — | — |
| All Other 4 | $76.0M | — | — | — |
Solventum Annual Revenue by Year
Solventum annual revenue history includes year-by-year totals (for example, 2025 revenue was $8.3B).
Solventum Quarterly Revenue & Net Profit History
Solventum results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $2.0B | -3.0% | $13.0M | 0.6% |
| Q4 FY2025 | $2.0B | -3.7% | $63.0M | 3.2% |
| Q3 FY2025 | $2.1B | +0.7% | $1.3B | 60.4% |
| Q2 FY2025 | $2.2B | +3.8% | $90.0M | 4.2% |
| Q1 FY2025 | $2.1B | +2.7% | $137.0M | 6.6% |
| Q4 FY2024 | $2.1B | — | $31.0M | 1.5% |
| Q3 FY2024 | $2.1B | +0.4% | $122.0M | 5.9% |
| Q2 FY2024 | $2.1B | +0.2% | $89.0M | 4.3% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.08B | $2.08B | $2.08B | $2.07B | $2.16B | $2.10B | $2.00B | $2.01B |
| YoY Growth | 0.2% | 0.4% | N/A | 2.7% | 3.8% | 0.7% | -3.7% | -3.0% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $14.58B | $14.74B | $14.46B | $14.53B | $15.07B | $13.97B | $14.29B | $14.10B |
| Liabilities | $11.71B | $11.55B | $11.50B | $11.27B | $11.43B | $8.99B | $9.24B | $9.13B |
| Equity | $2.87B | $3.19B | $2.96B | $3.26B | $3.65B | $4.99B | $5.05B | $4.97B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $355.0M | $169.0M | $219.0M | $29.0M | $169.0M | $76.0M | $95.0M |